This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Paul G. Dyment, MD; Edmund J. Doering, MD; Lee A. Asimont, MD

JAMA. 1979;241(8):829.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE TREATMENT of children with acute lymphocytic leukemia using current chemotherapy regimens along with radiotherapy and intrathecal chemotherapy for CNS prophylaxis has resulted in a large number of long-term survivors. Most of these patients continue in remission following cessation of three years or more of therapy.¹ However, these successfully treated patients have almost always been in continuous remission since their initial induction treatment at the time of diagnosis. Bone marrow or extramedullary relapse almost always heralds a series of recurrent relapses and progressively shorter remissions in children with acute lymphocytic leukemia.

A child underwent both testicular and bone marrow relapse at different times and yet subsequently has become apparently cured of his disease. He has been free of all signs of acute lymphocytic leukemia for the 11 years since his last relapse, even though his antileukemic therapy was stopped six years ago. We hope this report will encourage physicians . . . [Full Text PDF of this Article]

Author Affiliations
From the Section on Pediatric Hematology-Oncology, The Cleveland Clinic Foundation, Cleveland (Drs Dyment and Doering), and the Department of Hematology, Southern California Permanente Medical Group, Los Angeles (Dr Asimont).

Footnotes
Reprint requests to The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44106 (Dr Dyment).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?